Evidence map›Paper›PMID 20622703›Full record

Trial reportOptometry and vision science : official publication of the American Academy of Optometry2010

Spectacle lenses designed to reduce progression of myopia: 12-month results.

Padmaja Sankaridurg, Leslie Donovan, Saulius Varnas, Arthur Ho, Xiang Chen, Aldo Martinez, Scott Fisher, Zhi Lin, Earl L Smith, Jian Ge and 1 more

Erratum issuedAbstract readComparative StudyRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Optometry and vision science : official publication of the American Academy of Optometry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 94 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed, 8 pooled it
12.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 8 syntheses or guidelines pooled it, 291 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Interventions to slow progression of myopia in children.The Cochrane database of systematic reviews · 2020
    Pooled it
  7. Pooled it
  8. Interventions to slow progression of myopia in children.The Cochrane database of systematic reviews · 2011
    Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Myopia control with novel central and peripheral plus contact lenses and extended depth of focus contact lenses: 2 year results from a randomised clinical trial.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2019
    Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Padmaja SankaridurgInstitute for Eye Research, Sydney, New South Wales, Australia. p.sankaridurg@ier.org.au
Leslie Donovan
Saulius Varnas
Arthur Ho
Xiang Chen
Aldo Martinez
Scott Fisher
Zhi Lin
Earl L Smith
Jian Ge
Brien Holden
Fundação Armando Alvares Penteado · BRMetric Systems Corporation (United States) · USVision Eye Institute · AU

Funding

Research Programming ModuleP30EY007551 · NEI · UNIVERSITY OF HOUSTON · PI VALLABH E DAS · 1988 to 2026
$16.4M
NEI NIH HHS P30 EY007551
6 · The paper itself

Abstract

purposeTo report the results of 12-month wear of three novel spectacle lens designs intended to reduce peripheral hyperopic defocus and one standard design control lens and their effect on the progression of myopia in Chinese children aged 6 to 16 years.

methodsChinese children (n = 210) with myopia (-0.75 D to -3.50 D sphere, cylinder <or=-1.50 D) were randomized to one of four groups wearing either one of three novel spectacle lens designs (types I, II, or III) or conventional, single-vision spectacle lenses. Data were collected at 6 and 12 months. Primary and secondary outcome measures were the changes in central cycloplegic auto-refraction and eye axial length, respectively. Peripheral refraction along the horizontal meridian (nasal and temporal) was taken at baseline with and without spectacle lenses. Multivariate linear regression was used to adjust analyses for important covariates.

resultsProgression in eyes wearing control spectacle lenses at 6 and 12 months was -0.55 D +/- 0.35 D and -0.78 +/- 0.50 D, respectively. For the entire group, no statistically significant differences were observed in the rates of progression with the novel designs in comparison to control spectacle lenses. However, in younger children (6 to 12 years) with parental history of myopia (n = 100), there was significantly less progression (-0.68 D +/- 0.47 D vs. -0.97 D +/- 0.48 D) with lens type III compared with control spectacles (mean difference, 0.29 D, std error, 0.11, p = 0.038).

conclusionsThere were no statistically significant differences in the rate of progression of myopia between the control and novel lens wearing eyes for the age group 6 to 16 years. The finding of reduced progression of myopia with type III lens design in younger children with parental myopia needs to be validated in a more targeted study.

Indexed as

EyeglassesAdolescentAge FactorsAsian PeopleChildDisease ProgressionEquipment DesignFemaleFixation, OcularHumansHyperopiaInterviews as TopicLinear ModelsMaleMedical RecordsMyopia

Identifiers

PMID20622703
PMCPMC4696394
OpenAlexW2077157584

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.